Differential regulation of leukemia inhibitory factor-stimulated neuronal gene expression by protein phosphatases SHP-1 and SHP-2 through mitogen-activated protein kinase-dependent and -independent pathways
Jl. Bartoe et Nm. Nathanson, Differential regulation of leukemia inhibitory factor-stimulated neuronal gene expression by protein phosphatases SHP-1 and SHP-2 through mitogen-activated protein kinase-dependent and -independent pathways, J NEUROCHEM, 74(5), 2000, pp. 2021-2032
The neurally active cytokine leukemia inhibitory factor (LIF) signals throu
gh a bipartite receptor complex composed of LIF receptor alpha (LIFR) and g
p130. gp130 and LIFR contain consensus binding motifs for the protein tyros
ine phosphatase SHP-2 surrounding tyrosines 118 and 115 (Y118 and Y115) of
their cytoplasmic domains, respectively. These sites are necessary for maxi
mal activation of mitogen-activated protein kinase (MAPK). Coexpression of
catalytically inactive, but not wild-type, SHP-2 reduced LIFR- and gp130-me
diated activation of MAPK up to 75%. Conversely, coexpression of the wild-t
ype, but not catalytically inactive, SHP-1, a related phosphatase, reduced
activity up to 80%, demonstrating that SHP-2 and SHP-1 have opposing effect
s on the MAPK pathway. Mutation of Y115 of the cytoplasmic domain of LIFR e
liminates receptor-mediated tyrosine phosphorylation of SHP-2. In contrast,
SHP-1 association with gp130 and LIFR is constitutive and independent of Y
118 and Y115, respectively. SHP-1 has a positive regulatory role on LIF-sti
mulated vasoactive intestinal peptide (VIP) reporter gene expression in neu
ronal cells, whereas the effect of SHP-2 is negative. Furthermore, LIF-stim
ulated MAPK activation negatively regulates this VIP reporter gene inductio
n. SHP-2 also negatively regulates LIF-dependent expression of choline acet
yltransferase, but this regulation could be dissociated from its effects on
MAPK activation. These data indicate that SHP-1 and SHP-2 are important re
gulators of LIF-dependent neuronal gene expression via both MAPK-dependent
and -independent pathways.